StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Nyxoah S.A.
NasdaqGM:NYXH
Sector
Location
Market Cap
USD 297.73 M
Share Price
USD 7.86
Avg Daily Volume
169,742
Change (1 day)
1.16%
Change (1 year)
0.51%
Change (YTD)
-1.75%
Nyxoah S.A. Operating Income Margin for the Trailing 12 Months (TTM) ending December 31, 2024: -1,302.16%
Nyxoah S.A. Operating Income Margin is -1,302.16% for the Trailing 12 Months (TTM) ending December 31, 2024, a 25.20% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
-
Nyxoah S.A. Operating Income Margin for the Trailing 12 Months (TTM) ending December 31, 2023 was -1,040.05%, a 0.29% change year over year.
-
Nyxoah S.A. Operating Income Margin for the Trailing 12 Months (TTM) ending December 31, 2022 was -1,037.05%, a -66.37% change year over year.
-
Nyxoah S.A. Operating Income Margin for the Trailing 12 Months (TTM) ending December 31, 2021 was -3,083.71%, a -79.99% change year over year.
-
Nyxoah S.A. Operating Income Margin for the Trailing 12 Months (TTM) ending December 31, 2020 was -15,407.07%.
Competitors
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
GE HealthCare Technologies Inc.
USD 74.61
GEHC
-1.46
-1.92%
Natera, Inc.
USD 158.69
NTRA
-3.07
-1.90%
Laboratory Corporation of America Holdings
USD 257.87
LH
-4.02
-1.54%
Baxter International Inc.
USD 29.69
BAX
-1.32
-4.26%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%
ICON Public Limited Company
USD 147.59
ICLR
-2.51
-1.67%
Regencell Bioscience Holdings Limited
USD 18.43
RGC
-4.56
-19.84%
Ascendis Pharma A/S
USD 175.98
ASND
+1.80
1.03%
Exact Sciences Corporation
USD 52.48
EXAS
-0.88
-1.65%
ConvaTec Group Plc
USD 3.58
CTEC.L
-0.02
-0.59%
Guardant Health, Inc.
USD 49.54
GH
-0.96
-1.90%
Hangzhou Tigermed Consulting Co., Ltd.
USD 4.98
3347.HK
-0.10
-2.00%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.66
300832.SZ
-0.02
-0.30%
DiaSorin S.p.A.
USD 104.53
DIA.MI
-1.74
-1.63%
APT Medical Inc.
USD 40.48
688617.SS
+0.31
0.76%
Lantheus Holdings, Inc.
USD 79.19
LNTH
-1.23
-1.53%
Laurus Labs Limited
USD 8.99
LAURUSLABS.NS
-0.04
-0.46%
TransMedics Group, Inc.
USD 125.17
TMDX
-4.02
-3.12%
Key Data
| Date | Operating Income Margin | Gross Profit Margin | EBIT Margin | EBITDA Margin |
|---|
Competitors
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
GE HealthCare Technologies Inc.
USD 74.61
GEHC
-1.46
-1.92%
Natera, Inc.
USD 158.69
NTRA
-3.07
-1.90%
Laboratory Corporation of America Holdings
USD 257.87
LH
-4.02
-1.54%
Baxter International Inc.
USD 29.69
BAX
-1.32
-4.26%
Torrent Pharmaceuticals Limited
USD 38.81
TORNTPHARM.NS
-0.21
-0.53%
ICON Public Limited Company
USD 147.59
ICLR
-2.51
-1.67%
Regencell Bioscience Holdings Limited
USD 18.43
RGC
-4.56
-19.84%
Ascendis Pharma A/S
USD 175.98
ASND
+1.80
1.03%
Exact Sciences Corporation
USD 52.48
EXAS
-0.88
-1.65%
ConvaTec Group Plc
USD 3.58
CTEC.L
-0.02
-0.59%
Guardant Health, Inc.
USD 49.54
GH
-0.96
-1.90%
Hangzhou Tigermed Consulting Co., Ltd.
USD 4.98
3347.HK
-0.10
-2.00%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.66
300832.SZ
-0.02
-0.30%
DiaSorin S.p.A.
USD 104.53
DIA.MI
-1.74
-1.63%
APT Medical Inc.
USD 40.48
688617.SS
+0.31
0.76%
Lantheus Holdings, Inc.
USD 79.19
LNTH
-1.23
-1.53%
Laurus Labs Limited
USD 8.99
LAURUSLABS.NS
-0.04
-0.46%
TransMedics Group, Inc.
USD 125.17
TMDX
-4.02
-3.12%